Last reviewed · How we verify
NCT05790902
COMPARISON OF SILODOSIN AND TAMSULOSIN IN MEDICAL EXPULSIVE THERAPY OF DISTAL URETERIC CALCULI
Phase 1 trial testing Silodosin in Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi in 142 participants. Completed in 28 February 2023.
28 February 2023
Quick facts
| Lead sponsor | Armed Forces Institute of Urology, Rawalpindi |
|---|---|
| Phase | Phase 1 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 142 |
| Start date | 1 September 2022 |
| Primary completion | 28 February 2023 |
| Estimated completion | 28 February 2023 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Silodosin (SILODOSIN) — full drug profile →
- Tamsulosin (tamsulosin) — full drug profile →
Conditions studied
- Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi — all drugs for Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi →
Sponsor
Armed Forces Institute of Urology, Rawalpindi
Who can join
Adults 18 to 55, any sex, with Silodosin, Tamsulosin, Medical Expulsive Therapy, Distal Ureteric Calculi. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
to compare efficacy and safety of Silodosin and Tamsulosin in Medical expulsive therapy of Distal Ureteric Calculi.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05790902
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Silodosin
Trials testing the same drug.
- NCT07467343 — Silodosin vs Tamsulosin for LUTS Due to BPH: A Randomized Crossover Trial · Phase 4 · not yet recruiting
- NCT06114979 — Silodosin vs Placebo in the Treatment of Female LUTS · Phase 3 · unknown
- NCT06999135 — Comparison of Silodosin and Tamsulosin for Medical Expulsive Therapy in Patients With Ureteral Stones · NA · completed
- NCT06381206 — Silodosin in Management of Lower Ureteral Stones · Phase 1, PHASE2 · completed
- NCT07134907 — The Efficacy and Safety of Qianweitai (Silodosin Capsule) Versus Tamsulosin in the Treatment of BPH · Phase 4 · completed
Other Armed Forces Institute of Urology, Rawalpindi trials
Trials by the same sponsor.
- NCT06729346 — Is the Normal Looking Bladder Mucosa on WL Cystoscopy During TURBT Really Normal and Can NBI Detect Hidden Tumor · recruiting
- NCT07113782 — Comparison of Magnesium Sulphate vs Tramadol as Adjuvants in Intrathecal Bupivacaine for Postoperative Pain in TURP Pati · Phase 4 · completed
- NCT04676568 — Comparative Analysis of Outcome Between Extravesical and Transvesical Repair for Vesico-vaginal Fistula · NA · completed
- NCT04835116 — Comparison of Post-Operative Analgesia After Percutaneous Nephrolithotomy. · Phase 4 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05790902 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Armed Forces Institute of Urology, Rawalpindi
- Last refreshed: 30 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05790902.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing